Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In regional anesthesia local anaesthetics alone provide analgesia for not more than 4-8 hours. Increasing the duration of local anaesthetic action is often desirable because it prolongs surgical anaesthesia and analgesia. Different additives have been used to prolong regional blockade. Vasoconstrictors can be used to constrict vessels, thereby reducing vascular absorption of the local anaesthetic. Additives like opioids, clonidine and verapamil were added to local anaesthetics, but the results are either inconclusive or associated with side effects. Steroids when used intrathecally are reported to cause arachnoiditis, but there is no evidence suggesting any neuritis when steroids are used in low concentration in peripheral nerve blocks.
Steroids have powerful anti-inflammatory as well as analgesic properties. Perineural injection of steroids is reported to influence postoperative analgesia. They relieve pain by reducing inflammation, and blocking transmission of nociceptive C-fibres and by suppressing ectopic neural discharge. The addition of 5 mg of dexamethasone to 10 ml of 0.5% levobupivacaine in interscalene brachial plexus block showed improvement of postoperative analgesia for arthroscopic shoulder operation without any specific complications.
The objective of this study is to compare the effects of combining of dexamethasone and bupivacaine versus bupivacaine alone in combined femoral and sciatic nerve block in patients undergoing lower limb vascular surgeries. The effects will be studied in terms of:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| perineural dexamethasone group | Active Comparator | 21 patients received perineural dexamethasone plus bupivacaine 0.5% |
|
| systemic dexamethasone group | Active Comparator | 21 patients received systemic (intravenous) dexamethasone plus perineural bupivacaine 0.5% |
|
| control group | Sham Comparator | 21 patients received only perineural bupivacaine 0.5% plus intravenous saline |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Perineural Dexamethasone and bupivacaine | Drug |
| ||
| Systemic Dexamethasone plus perineural bupivacaine |
| Measure | Description | Time Frame |
|---|---|---|
| Time of onset of sensory blockade | from time of performing the nerve block till the occurrence of sensory block | upto 30 min |
| Time of onset of motor blockade | from time of performing the nerve block till the occurrence of motor block | up to 30 min |
| Duration of analgesia | time from onset of analgesia till the first request for an analgesic | upto 24 hours |
| Duration of motor blockade | time from motor blockade till ability to move the limb | upto 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| perioperative hemodynamics | systolic and diastolic blood pressure, heart rate before starting the procedure;Respiratory rate;and Oxygen saturation during the procedure and in the 24 hours following the procedure | time immediately before block and every 30 minutes till end of surgery and 24 hours after surgery (1 hour interval) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
|
| intravenous saline plus perineural bupivacaine | Drug |
|
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
| D000588 | Amines |
Not provided
Not provided